Your question is narrower than their market map.
A syndicated report is a polished snapshot of a vendor's view of a whole market. Signals is scoped to the question on your desk, grounded in sources you can open, and re-runnable when the market moves.
- Today: buyers pay for a trusted market view they can cite internally.
- Problem: the report is broad, fixed, and shaped for many buyers.
- Signals starts from your briefing and refreshes when the decision moves.
Reach for a syndicated analyst report when
- You want a recognized third party's name on a market view for credibility.
- The standard market framing is genuinely what you need.
- You don't need the analysis to track your specific portfolio or thesis.
Reach for Signals when
- Your question is narrower or stranger than any syndicated report covers.
- You need to inspect the underlying sources before accepting the conclusion.
- The topic moves faster than the report's publishing cycle.
| Analyst reports | Signals | |
|---|---|---|
| Scope | A whole market, framed for the median buyer. | Your exact briefing: objectives, scope, and constraints you set. |
| Freshness | Fixed at publication; the next update is on the analyst's calendar. | Re-run a workflow whenever the picture changes; Sessions capture each pass. |
| Evidence access | Conclusions are stated; the working sources are usually not yours to inspect. | Every signal links to its Sources with verdicts and a grounding state you can inspect. |
| Adaptability | You adapt your thinking to the report's framing. | Categories, tag sets, frames, and metrics are yours to shape around how your team thinks. |
| Cost shape | Per-seat subscription or per-report license, regardless of use. | Credit-based: you spend on the research you run. |
| Defensibility | "The analyst said so." | "Here are the sources, the verdicts, and how the conclusion was grounded." |
A question a buyer would bring
"Which emerging payments-infrastructure shifts threaten our fintech roadmap?"
Run this as a free scan →And here’s what an answer looks like.
A real finding from a recent run, merged where models agreed, scored, dated, and tied back to sources.
What is changing across AI-driven drug discovery platforms, GLP-1 follow-ons, and the shifting economics of clinical trials?
Synthetic Control Arm Adoption
Buy the report when you need the analyst brand. Run Signals when you need research scoped to your question, with evidence your team can inspect.
Other comparisons
“ Signals research made my year! ”
Arijana Drinic
Head of Exploration
Test Signals against analyst reports.
Bring the question you would normally put into a chat, report brief, or consulting kickoff.